Daye

Daye now offers tampon-based STI screening — starting in the UK

U.K. femcare-turned-gynaecological-health startup, Daye, has expanded its tampon-based home screening service to add STI testing. The startup is billing this “non-invasive screening” servi

UK femtech Daye launches virtual clinic for period pain

U.K. women’s health Daye has a new string to its bow: It’s opened what it’s billing as the world’s first virtual period pain clinic. The new service, which extends the startup&

Starting the tampon revolution with Valentina Milanova

Welcome back to Found, where we get the stories behind the startups. This week the show kicks off a new season and welcomes a new co-host. In this episode, Darrell is joined by Becca Szkutak to chat w

Flush with Series A funding, Daye unwraps the big gynae health mission

Talking to Valentina Milanova, the still just 28-year-old founder of U.K. femtech Daye, is best described as an exhilarating experience. During our interview, she talks in and around her topic —

Index Fund’s portfolio is driving long-overdue innovation in femcare

U.K. startup Daye is rethinking female intimate care from a woman’s perspective, starting with a tampon infused with cannabidiol that tackles period pain. It’s also quietly demolishing the retrogr

Daye, a startup developing a ‘cramp-fighting’ tampon, raises $5.5M from Khosla, Index and Kindred

Daye, a “femcare” startup developing a new type of tampon that uses CBD to help tackle dysmenorrhea, has quietly raised $5.5 million in funding from high-profile investors in the U.S. and